Innovation Pharmaceuticals Inc (IPIX)

[noretreat]

and here is another way of looking at the same data:

"...I have used the same statistics for the past 2 decades which are for all new drugs. Drugs in phase I have 8% chance of making to the market, Phase II drugs 24% and Phase III drugs 54% probability, NDA filed drugs 75%. These rates were coming down for the past decade..."